VLA 0.00% $1.75 viralytics limited

Latest clinical trial results, page-11

  1. 222 Posts.
    lightbulb Created with Sketch. 9
    Hi Lopez

    The Keynote 200 trial looks like it is tracking well and the upregulation of PD-L1 in NSCLC and bladder cancer looks promising.

    I'm still disappointed at the pace of the MITCI & CAPRA trials .... still recruiting very slowly but the results are looking excellent.

    I think today's announcement will help to clarify the results from the presentation.

    GLTAH
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.